Teva to divest active pharmaceutical ingredient business
Source: Reuters Teva Pharmaceutical Industries (TEVA.TA), opens new tab will divest its active pharmaceutical ingredient (API) unit to focus on its core business, the world’s largest generic drugs maker said on Wednesday. The API unit, which brought in revenue of $1.05 billion in 2022, makes pharmaceutical ingredients that are used in both generic and branded medicines, and […]
Panacea Biotech’s Baddi unit gets OAI status from USFDA
Source: CNBCTV18 Panacea Biotech informed the exchanges that the United States Food & Drug Administration (USFDA) has classified the company’s Baddi facility in Himachal Pradesh as an “Official Action Indicated” (OAI). The facility was issued a form-483 by the drug regulator with nine observations in October, which were related to improvements in existing procedures. An […]